The role of connexin 43 in preconditioning. Impact on mitochondrial function;Rola koneksyny 43 w regulacji funkcji mitochondriów podczas zjawiska hartowania (preconditioning)

Kardiologia Polska

Volumn 68, Issue 1, 2010, Pages 91-96

  Janczarska, Katarzyna ^a   Kieć Wilk, Beata ^a   Leszczyńska Goła̧bek, Iwona ^a   Malczewska Malec, Małgorzata ^a   Bodzioch, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CELL ADHESION MOLECULE; CONNEXIN 43; MESSENGER RNA; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

CELL ADHESION; CELL FUNCTION; GAP JUNCTION; HEART MUSCLE CELL; HEREDITARY MOTOR SENSORY NEUROPATHY; HOMEOSTASIS; HYPERHOMOCYSTEINEMIA; METABOLISM; MITOCHONDRION; REVIEW;

EID: 76749132809     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Jiang JX, Gu S. Gap junction- and hemichannel-independent actions of connexins. Biochim Biophys Acta 2005; 1711: 208-14.
2. De Maio A, Vega VL, Contreras JE. Gap junction, homeostasis, and injury. J Cell Physiol 2002; 191: 269-82.
3. Dejana E, Corada M, Lampugnani MG. Endothelial cell-to-cell junctions. FASEB J 1995; 9: 910-8.
4. Lampugnani MG, Dejana E. Interendothelial junctions: structure, signalling and functional roles. Curr Opin Cell Biol 1997; 9: 674-82.
5. Sosinsky GE, Nicholson BJ. Structural organization of gap junction channels. Biochim Biophys Acta 2005; 1711: 99-125.
6. Kańczuga-Koda L. Znaczenie poła̧czeń typu gap w fizjologii i patofizjologii przewodu pokarmowego. Postepy Hig Med Dosw 2004; 58: 158-65.
7. Oyamada M, Oyamada Y, Takamatsu T. Regulation of connexin expression. Biochim Biophys Acta 2005; 1719: 6-23.
8. Rutkowski R, Kosztyła-Hojna B, Kańczuga-Koda L, et al. Struktura i fizjologiczna funkcja białek koneksynowych. Postepy Hig Med Dosw 2008; 62: 632-41.
9. Griffith TM. Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br J Pharmacol 2004; 141: 881-903.
10. Kozłowska H, Baranowska M, Gromotowicz A, et al. EDHF - śródbłonkowy czynnik hiperpolaryzujácy. Znaczenie w fizjologii i chorobach naczyń krwionośnych. Postepy Hig Med Dosw 2007; 61: 555-64.
11. Alex J, Cale ARJ, Griffin SC, et al. Connexins: the basis of functional coupling of myocytes guvendik. J Clin Basic Cardiol 2005; 8: 19-22.
12. Pytkowski M, Kaczorowska M. Mutacje somatyczne w genie koduja̧cym białko koneksynȩ 40 (GJA5) u chorych z migotaniem przedsionków. N Engl J Med 2006; 354: 2677-88.
13. Kliszek M, Małek ŁA, Koźluk E, et al. Genetyczne uwarunkowania najczȩstszych arytmii. Kardiol Pol 2006; 64: 601-5.
14. Płotek W. Budowa i funkcje synaps elektrycznych (gap junctions) w ośrodkowym układzie nerwowym. Anestezjologia i Ratownictwo 2008; 2: 274-82.
15. Oviedo-Orta E, Evans WH. Gap junction and connexin-mediated communication in the immune system. Biochim Biophys Acta 2004; 1662: 102-12.
16. Sohl G, Willecke K. Gap junction and the connexin protein family. Cardiovasc Res 2004; 62: 228-32.
17. Koval M. Pathways and control of connexin oligomerization. Trends Cell Biol 2006; 16: 159-66.
18. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intracellular signaling. Eur J Biochem 1996; 238: 1-27.
19. Harris AL, Darren L. Connexins, a guide. Humana Press New York: Springer 2008; 574.
20. Kanemitsu MY, Lau AF. Epidermal growth factor stimulates the disruption of gap junctional communication and connexin 43 phosphorylation independent of 12-0-tetradecanoylphorbol 13-acetate-sensitive protein kinase C: the possible involvement of mitogen-activated protein kinase. Mol Biol Cell 1993; 4: 837-48.
21. Shiokawa-Sawada M, Mano M, Hanada K, et al. Down-regulation og gap junctional intracellular communication between osteoblastic MC3T3-E1 cells by basic fibroblast growth factor and a phorbol ester (12-0-tetradecanoylphorbol 13-acetate). J Bone Miner Res 1997; 12: 1165-73.
22. Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr Mol Med 2007; 7: 85-102.
23. Hellebrekers DM, Griffioen AW, van Engeland M. Dual targeting of epigenetic therapy in cancer. Biochim Biophys Acta 2007; 1775: 76-91.
24. Kiec-Wilk B, Polus A, Mikolajczyk M, Mathers JC. Beta-carotene and arachidonic acid induced DNA methylation and the regulation of pro-chemotactic activity of endothelial cells and its progenitors. J Physiol Pharmacol 2007; 58: 757-66.
25. Li H, Brodsky S, Kumari S, et al. Paradoxical overexpresion and translocation of connexin 43 in homocysteine-treated endothelial cells. Am J Physiol Heart Circ Physiol 2002; 282: 2124-33.
26. Miura T, Ohnuma Y, Kuno A, et al. Protectice role of gap junctions in preconditioning against myocardial infraction. Am J Physiol Heart Circ Physiol 2004; 286: 214-21.
27. Boengler K, Dodoni G, Rodriguez-Sinovas A, et al. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 2005; 67: 234-44.
28. Hatanaka K, Kawata H, Toyofuku T, et al. Down-regulation of connexin 43 in early myocardial ischemia and protective effect by ischemic preconditioning in rat hearts in vivo. Jpn Heart J November 2004; 45: 1007-19.
29. Liu LZ, Hu XW, Xia C, et al. Reactive oxygen spieces regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 2006; 41: 1521-33.
30. Lim KH, Javado SA, Das M, et al. The effect of ischemic preconditioning, diazodide and 5-hydroksydecanoate on rat hart mitochondria volume and respiration. J Physiol 2002; 545: 961-74.
31. Rodriguez-Sinovas A, Cabestrero A, Lopez D, et al. The modulatory effects of connexin 43 on cell death/survival beyond cell coupling. Prog Biophys Mol Biol 2007; 94: 219-32.
32. Schwanke U, Konietzka I, Duschin A, et al. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 2002; 283: 1740-2.
33. Wiȩckowski MR. Mitochondrialny megakanał w fizjologii i patologii komórki - nowe spojrzenie. Postȩpy Biochem 2008; 54: 71-81.
34. Rupniewska Z, Bojarska-Junak A. Apoptoza: Przepuszczalność błony mitochondrialnej i rola pełniona przez białka z rodziny Bcl-2. Postepy Hig Med Dosw 2004; 58: 538-47.
35. Suleiman MS, Halestrap AP, Griffiths EJ. Mitochondria: a target for myocardial protection. Pharmacol Ther 2001; 89: 29-46.
36. Hausenloy DJ, Cellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 2003; 35: 339-41
37. Han D, Antunes F, Canali R, et al. Voltage-dependent anion chanels control the release of the superoxide anion from the mitochondria to cytosol. J Biol Chem 2003; 278: 5557-63.
38. Griffiths EJ, Halestrap AP. Protection by cyclosporine of ichemia/reperfusion-induced damage in isolated hearth death. J Mol Cell Cardiol 1993; 25: 1461-9.
39. Dembińska-Kieć A. Modyfikacja przepuszczalności błon mitochondrialnych w mechanizmie hartowania przez niedokrwienie. Rola receptorów opioidowych. Kardiol Pol 2006; 64: 159-60.
40. th September 2008 Potsdam Nutrient Sensing.
41. Holmuhamedov EL, Jovanovic S, Dzejaet PP, et al. Mitochondrial ATP-sensitice K+ channels modulate cardiac mitochondrial function. Am J Physiol Heart Circ Physiol 1998; 275: 1567-76.
42. Pain T, Yang XM, Critz SD, et al. Opening of mitochondrial K (ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 2000; 7: 460-6.
43. Boengler K, Stahlhofen S, van de Sand A, et al. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomiocyte mitochondria. Basic Res Cardiol 2009; 104: 141-7.